State of the art in vivo imaging techniques for laboratory animals
- PMID: 28948893
- DOI: 10.1177/0023677217695852
State of the art in vivo imaging techniques for laboratory animals
Abstract
In recent decades, imaging devices have become indispensable tools in the basic sciences, in preclinical research and in modern drug development. The rapidly evolving high-resolution in vivo imaging technologies provide a unique opportunity for studying biological processes of living organisms in real time on a molecular level. State of the art small-animal imaging modalities provide non-invasive images rich in quantitative anatomical and functional information, which renders longitudinal studies possible allowing precise monitoring of disease progression and response to therapy in models of different diseases. The number of animals in a scientific investigation can be substantially reduced using imaging techniques, which is in full compliance with the ethical endeavours for the 3R (reduction, refinement, replacement) policies formulated by Russell and Burch; furthermore, biological variability can be alleviated, as each animal serves as its own control. The most suitable and commonly used imaging modalities for in vivo small-animal imaging are optical imaging (OI), ultrasonography (US), computed tomography (CT), magnetic resonance imaging (MRI), and finally the methods of nuclear medicine: positron emission tomography (PET) and single photon emission computed tomography (SPECT).
Keywords: CT; MRI; imaging modalities; molecular imaging; optical imaging.
Similar articles
-
Preclinical imaging: an essential ally in modern biosciences.Mol Diagn Ther. 2014 Apr;18(2):153-73. doi: 10.1007/s40291-013-0062-3. Mol Diagn Ther. 2014. PMID: 24146172 Review.
-
Rationale for the combination of nuclear medicine with magnetic resonance for pre-clinical imaging.Technol Cancer Res Treat. 2006 Aug;5(4):343-50. doi: 10.1177/153303460600500406. Technol Cancer Res Treat. 2006. PMID: 16866565
-
[Hybrid imaging: clinical evidence, opportunities].Orv Hetil. 2015 Dec 27;156(52):2110-5. doi: 10.1556/650.2015.30324. Orv Hetil. 2015. PMID: 26686747 Review. Hungarian.
-
In vivo imaging in humanized mice.Curr Top Microbiol Immunol. 2008;324:179-96. doi: 10.1007/978-3-540-75647-7_12. Curr Top Microbiol Immunol. 2008. PMID: 18481461 Review.
-
Hybrid imaging technology: from dreams and vision to clinical devices.Semin Nucl Med. 2009 Jul;39(4):247-63. doi: 10.1053/j.semnuclmed.2009.03.005. Semin Nucl Med. 2009. PMID: 19497402 Review.
Cited by
-
Orally Deliverable Dual-Targeted Pellets for the Synergistic Treatment of Ulcerative Colitis.Drug Des Devel Ther. 2021 Sep 29;15:4105-4123. doi: 10.2147/DDDT.S322702. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34616144 Free PMC article.
-
Optimization of In Vivo Studies by Combining Planar Dynamic and Tomographic Imaging: Workflow Evaluation on a Superparamagnetic Nanoparticles System.Mol Imaging. 2021 Jan 15;2021:6677847. doi: 10.1155/2021/6677847. eCollection 2021. Mol Imaging. 2021. PMID: 33746630 Free PMC article.
-
Spontaneous and Induced Animal Models for Cancer Research.Diagnostics (Basel). 2020 Aug 31;10(9):660. doi: 10.3390/diagnostics10090660. Diagnostics (Basel). 2020. PMID: 32878340 Free PMC article. Review.
-
Identification of Novel Bromodomain-Containing Protein 4 (BRD4) Binders through 3D Pharmacophore-Based Repositioning Screening Campaign.Molecules. 2024 Aug 26;29(17):4025. doi: 10.3390/molecules29174025. Molecules. 2024. PMID: 39274873 Free PMC article.
-
Noninvasive in vivo cell tracking using molecular imaging: A useful tool for developing mesenchymal stem cell-based cancer treatment.World J Stem Cells. 2020 Dec 26;12(12):1492-1510. doi: 10.4252/wjsc.v12.i12.1492. World J Stem Cells. 2020. PMID: 33505597 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical